Hypertension in adults: diagnosis and management
KEYWORDS: blood, pressure, blood pressure, people, treatment, hypertension, committee, evidence, recommendations, cardiovascular, recommendation, disease, guideline, step, diabetes

looked at this evidence alongside the new dual therapy evidence review, they concluded that it was insufficient to recommend starting dual therapy in any subgroup of people with type 2 diabetes. The committee noted that people with type 2 diabetes who are older or are of Black African or African–Caribbean family origin may not achieve their target blood pressure on ACE inhibitor or ARB monotherapy and may need to start step 2 drug therapy in the short term. How the recommendations might affect practice Overall, the recommendations for step 1 treatment reflect current practice for people who do not have type 2 diabetes. For people of Black African or African–Caribbean family origin who have type 2 diabetes, the recommendation to start antihypertensive monotherapy rather than dual therapy may result in an extra clinical appointment if the dose needs to be adjusted. However, it may also reduce potential harms from initial overtreatment of blood pressure. Return to recommendations Step 2 and 3 treatment Recommendations 1.4.40 to 1.4.45 Why the committee made the recommendations No evidence for step 2 or step 3 treatment was identified that was relevant to determining the best sequence for step 2 and step 3 antihypertensive treatment. Some
